Cyanotech Announces Delayed Filing of Annual Financial Statements
KAILUA KONA, Hawaii (June 29, 2015) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), reported today that its 2015 Annual Report has been delayed.
The Company has experienced a delay in completing the necessary disclosures and finalizing its financial statements in connection with its Annual Report on Form 10-K for the year ended March 31, 2015 (the “Annual Report”). As a result of this delay, the Registrant was unable without unreasonable effort or expense to file its Annual Report by the prescribed filing date. The Company anticipates filing its Annual Report and related XBRL documents on or before the extended deadline of July 14, 2015.
About Cyanotech — Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®—all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA-reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at our 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech sells its products direct to consumers at retail locations in the United States and online at www.nutrex-hawaii.com and also distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers worldwide and is GMP-certified by the Natural Products AssociationTM. Visit www.cyanotech.com for more information.
Bruce Russell: email@example.com